Bafna Pharmaceuticals doubles sales of Raricap

10 May 2013 Evaluate

Bafna Pharmaceuticals, a Chennai-based Pharma company, has doubled the sales of Raricap over the previous year. The company had acquired legacy Brand Raricap two years ago. Raricap is the only brand available in the market with a unique iron salt Ferrous Calcium Citrate (FCC). Ferrous Calcium Citrate a complex salt benefits the patients by enhancing dietary iron absorption unlike other conventional salts.

Sales of Raricap during FY 2012-13 were Rs 16.15 crore against Rs 7.78 crore in FY 2011- 12. Moreover, the sales of Raricap in April 2013 were registered at Rs 2.18 crore. Within 2nd year of launch, Raricap has reached 22nd position as per AIOCD (Mar '13 MAT Value) in haematinic segment.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum.  The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

85.54 -4.50 (-5.00%)
03-Jun-2024 13:48 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1462.25
Dr. Reddys Lab 5794.30
Cipla 1449.85
Zydus Lifesciences 1027.90
Lupin 1583.45
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.